28 algorithm-development-"Multiple"-"Simons-Foundation"-"Prof"-"UNIS" Fellowship positions at City of Hope
Sort by
Refine Your Search
-
discovery approaches and biochemical assays to target key proteins. This funded position is for a postdoctoral trainee interested in aiding the development of novel therapeutics for treating cancer
-
, 2025), Science Immunology (2023, 2024), Molecular Cell (2025), Cancer Discovery (2019), JEM, PNAS, and Trends in Immunology. Dr. Ma’s research has been recognized with multiple national and institutional
-
therapeutics or nucleic-acid chemistry o Nanoparticle / liposome formulation and characterization o HTS assay development and robotic screening o Recombinant protein expression in multiple hosts o
-
, shaping the future of medicine through cutting-edge research. The Jianjun Chen Lab at City of Hope is looking for talented Postdoctoral Fellows to study cancer and stem cell biology. There are multiple
-
) development of small molecule drugs and PROTAC-drug conjugates. The Li group conducts the most forefront science and is highly productive with publications in high-impact journals in the past five years, Nature
-
are working on this may be the perfect opportunity: 1. Development of cell-free DNA (mutation and methylation), RNA, and exosomal-based liquid assays for early cancer detection, prognosis, and predictive
-
, FOLFOX-3B—all of which completed with numerous biomarker-driven projects pending). Participate in paper writing of multiple research projects. Data sets will be electronic. No biological samples will be
-
studies. The lab focuses on mechanisms underlying human T-cell development and lymphoid leukemogenesis and the application of these mechanistic insights to the development of novel anti-cancer immunotherapy
-
presentation, ability to work efficiently in a team and with collaborators · Experience in Single Cell Multi-omics techniques and multiple component analysis programs is an advantage · Previous
-
metabolic syndrome · Utilize multiple cutting-edge technologies, including spatial transcriptomics and single nuclei multiomics, to dissect the molecular mechanisms of cardiomyopathy under diabetes